Acute Intermittent Porphyria Market: Rising Awareness and Advances in Therapeutics Supporting Growth 🧬
The global acute intermittent porphyria (AIP) market is gradually expanding as awareness of rare metabolic disorders increases and healthcare systems strengthen diagnostic and treatment capabilities. The market was valued at US$ 4.6 Mn in 2023 and is projected to grow at a CAGR of 3.9% from 2024 to 2034, reaching approximately US$ 7.1 Mn by the end of 2034. Growth is primarily driven by rising...
0 Σχόλια 0 Μοιράστηκε 91 Views 0 Προεπισκόπηση